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Introduction
Implanon NXT (Merck & Co. Inc., Whitehouse Station, NJ, 
USA) is a single-rod subdermal contraceptive implant that 
consists mainly of selective progestin etonogestrel (ENG) 
and ethylene vinyl acetated (EVA) copolymer that is sur-
rounded by a rate-controlling EVA membrane [1]. A single 
implant contains 68 mg of ENG, which is released slowly and 
steadily in doses of 60–70 mg/day [2]. It has been widely 
used throughout the world, providing effective contracep-
tive protection for up to 3 years and does not rely on user 
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Objective
The aim of this study was to present experiences in localization and removal of non-palpable subdermal contraceptive 
implants with ultrasonography.
Methods
Medical records from January 1, 2016, to April 30, 2018, were retrospectively reviewed for 21 patients who 
were referred to a single institution and had an impalpable implant despite following the removal instruction. 
In all the cases, more than one attempt was made to remove the implant before referral. The rod was detected 
using radiography and ultrasonography. In all the cases, localization of the single implant was achieved with 
ultrasonography. The distal depth of the rod was measured, and skin marking was made following the echogenicity. 
The implants were subsequently removed under anesthesia.
Results
In 18 cases, the rods were localized using ultrasonography and successfully removed under local anesthesia. 
In the other three cases, removal with local anesthesia failed. Although the rod was detected successful with 
ultrasonography, the implants were removed under general anesthesia in the operating room. The depth from skin 
to rod, measured with ultrasonography, was >12.0 mm in all the cases and located deep in the muscular layer in the 
failure cases. The depth of the implants positively correlated with the time spent for removal (r=0.525; P=0.015).
Conclusion
High frequency ultrasonography is a highly accurate tool for localization and measurement of the skin-to-rod depth. 
It is also useful for removing non-palpable implants. If the depth of the implant is >12.0 mm, removal of the implant 
in the operating room under general anesthesia is recommended.
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compliance [2]. The implant is easily inserted and removed 
when insertion is performed properly according to the prod-
uct instructions. It is estimated that only a small proportion 
of implants is incorrectly inserted and that <0.1% results in 
difficult removals [3]. Deep or non-palpable implants can oc-
cur owing to migration, fibrosis, or weight gain, and often 
require referrals to experienced clinicians who would use ul-
trasonography or other imaging tools for removal.
Palpable implants can be easily removed without any im-
aging guidance through a 2-mm incision near the tip of the 
rod [4]. However, when inserted improperly or migrated to 
other places, the implant can be difficult to localize by palpa-
tion, and consequently, removal can become complicated. In 
these cases, follow-up imaging studies should be conducted 
to establish the strategies for non-palpable implants. Ultra-
sonography is the most powerful and widely available mo-
dality, but it can hardly detect distant migration. Moreover, 
measurement of implant depth with ultrasonography tends 
to be underestimated as a result of tissue compression. Two-
dimensional radiography can be useful not only for visual-
izing distant migration but also for revising the discordance 
between measurement using ultrasonography and the actual 
depth from the skin since a radiopaque implant has been de-
veloped [5].
Previous studies demonstrated different approaches for 
localization and removal of implants. Singh et al. [6] intro-
duced ultrasonography as a localizing modality to remove 
non-palpable implants under general anesthesia. James and 
Trenery [4] introduced the removal of impalpable rods with 
real-time ultrasonography guidance. However, none of these 
studies suggested strategies for localizing and removing 
barely palpable implants under local anesthesia in the outpa-
tient clinic. They did not provide a cutoff point for the need 
for general anesthesia.
Therefore, the aim of this study was to present experi-
ences in localization and removal of non-palpable subdermal 
implants with ultrasonography under local anesthesia by a 
single experienced skillful clinician in a single institution.
Materials and methods
Our retrospective study included a review of the medical 
records of 21 patients who were referred to the outpatient 
clinic of the gynecology department of Gangnam Sever-
ance Hospital because of an impalpable or barely palpable 
subdermal contraceptive implant between January 1, 2016, 
and April 30, 2018. In all the cases, more than one attempt 
was made to remove the rods before referral, but removal 
of the implanted device failed despite following the removal 
instruction. Prior to using ultrasonography, two-dimensional 
radiography was performed to confirm whether the rod was 
placed. The radiologist recorded whether the implant was 
clearly visible or invisible in both lateral and anteroposterior 
views.
The ultrasonography detection of the rod was performed 
using a 5- to 12-MHz linear array probe with an iU22 scan-
ner (Philips Medical Systems, Best, The Netherlands) by an 
experienced radiologist. The patient lied on her back on the 
examination table, with her arms flexed at the elbow and 
externally rotated. Ultrasonography scanning was started 
from the site where the implant was expected to be pres-
ent, which was assumed through radiography and skin scars 
associated with insertion or removal. The scanning was per-
formed in the transverse plane, as this was known to be opti-
mal because the implant was visualized as an echogenic spot 
casting a posterior acoustic shadowing [7]. Tissue harmonic 
mode was used for the scanning, as this was shown to be 
the best for the detection of implants because it produces 
the most prominent posterior acoustic shadow in a previous 
study [8]. The radiologist measured the depth of the implant 
from the skin surface. After the full length of the implant 
was identified, skin marking was made from the proximal to 
the distal tip (Fig. 1).
In all the cases, the implants were radiopaque on radio-
graphs (Fig. 2). On ultrasonography, all the implants were de-
picted as echogenic spots with a posterior acoustic shadow, 
which is the signature appearance of implants on ultraso-
nography. The posterior acoustic shadow is a thin and dark 
wedge shape created by the implant, extending deep to the 
rod [6] (Fig. 3). This shadow occurs because the implant has 
a different acoustic impedance compared with the adjacent 
soft tissue [7].
Localized non-palpable implants were subsequently re-
moved under local anesthesia in the outpatient setting. With 
2% lidocaine injected along the skin marking, a 5-mm inci-
sion, 1 cm from the distal tip, was made perpendicular to 
the marking. The implant location could be predicted by the 
depth measured with ultrasonography. By using the tip of 
sterilized forceps and hemostat, the distal tip of the implant 
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was pulled. During the procedure, the clinician checked for 
jerkiness or movement abnormality of the patient. The full 
length of the removed rod was confirmed to be 4 cm to en-
sure that complete removal was achieved (Fig. 4).
In patients who complained of pain while removal was at-
tempted under local anesthesia (cases 19 and 21) or those in 
whom no implant was found (case 20), exploration for sub-
dermal devices was discontinued and implant removal was 
attempted in the operating room under general anesthesia. 
The time spent for successful removal was recorded. In cases 
of failure of removal, the time spent for exploration without 
finding the implant was recorded.
Data were presented as mean±standard deviation. The 
Spearman rho was used to measure the strength of the as-
sociation between the variables. All the analyses were per-
formed using IBM SPSS Statistics version 23.0 for Windows 
(IBM Corp., Armonk, NY, USA), and a P-value of <0.05 was 
considered statistically significant.
Fig. 1. Skin marking made from the proximal to the distal tip with 
ultrasonography localization.
Fig. 3. Implant and posterior acoustic shadow in transverse view 
(arrow). A posterior acoustic shadow is the signature appearance 
of implants on ultrasonography, which is a thin and dark wedge 
shape created by implant, extending deep to the rod.
Fig. 4. The full length of the removed rod was confirmed to be 
4 cm, ensuring that complete removal was achieved.
Fig. 2. A radiopaque implant clearly visible on the radiograph (ar-
rows).
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Results
Twenty-one patients with non-palpable subdermal implants 
were referred to the center. Table 1 presents the details of 
the clinical characteristics of the study participants and the 
reasons for implant removal. Their ages ranged from 27 
and 47 years, with a mean age of 35.8±1.4 years. Body 
mass index (BMI) ranged from 17.9 to 25.8 kg/cm2, and the 
mean value was 21.0±0.5 kg/cm2. The interval between the 
insertion and the request for removal ranged from 2 to 72 
months, with a mean duration of 28.4±1.8 months. The 
most common reason for requesting removal was abnormal 
uterine bleeding (n=8, 38.1%), followed by arm pain (n=6, 
28.6%) and implant exchange (n=3, 14.3%), weight gain 
(n=2, 0.1%), and pregnancy (n=2, 0.1%).
Table 2 shows the details of the measurements during the 
procedure and the ultrasonography findings. It shows the 
locations of the implants, whether within the adipose tissue, 
muscle layer, or overlying fascia. The depth of the rods was 
measured at the distal tip of the implant. The mean depth of 
the implants was 7.9 mm.
Table 3 demonstrates the correlation between BMI, age, 
depth, time spent for removal with local anesthesia, and du-
ration between insertion and removal of the device. Implant 
depth positively correlated with the time spent for removal 
(r=0.525; P=0.015). The deeper the implants are located, 
the longer it takes to remove them. Neither BMI and depth 
(r=−0.052; P=0.822) nor BMI and time (r=0.158; P=0.495) 
had a correlation. No significant correlation was found be-
tween the time spent for removal and the duration from 
insertion to removal of the implant (r=0.300; P=0.186) using 
the Spearman correlation.
In 18 cases, the rods were localized using ultrasonography, 
where the skin was marked and successfully removed under 
local anesthesia in the outpatient setting. The mean removal 
time was 6.1±4.6 minutes. In cases 19, 20, and 21, the 
mean time spent for trying to remove but eventually stop-
ping because of pain in the arm or exploring for implants but 
Table 1. Clinical characteristics of study participants and reasons for removal
Case Age (yr) BMI Duration (mon) Reason for removal
1 32 18.8 36 Abnormal uterine bleeding
2 32 20.4 12 Arm pain
3 33 25.8 8 Arm pain
4 41 21.4 25 Abnormal uterine bleeding
5 45 22.7 37 Weight gain
6 42 19.5 36 Abnormal uterine bleeding
7 44 21.6 2 Arm pain
8 31 19.3 29 For pregnancy
9 45 18.7 42 Abnormal uterine bleeding
10 47 20.1 36 For exchange
11 36 23.1 28 Abnormal uterine bleeding
12 27 20.3 36 For pregnancy
13 32 25.1 26 Arm pain
14 37 18.9 22 Abnormal uterine bleeding
15 31 22.5 7 Arm pain
16 42 21.3 40 Weight gain
17 29 17.9 20 Abnormal uterine bleeding
18 27 20.6 19 Abnormal uterine bleeding
19 34 21.3 72 For exchange
20 33 22.7 30 Arm pain
21 33 18.6 34 For exchange
BMI, body mass index.
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eventually failing to find an implant was 26.7±2.9 minutes. 
The mean depth of the implants successfully removed with 
local anesthesia was 7.2±2.7 mm, while the mean depth in 
the cases of failed removal was 12.7±0.7 mm (Table 3). The 
best cutoff depth of the implants was 12.0 mm (sensitivity, 
0.935 and 1-specificity, <0.001). All of them were located 
deeper than the muscle fascia or muscular layer.
Discussion
Following the instructions for insertion, a subdermal contra-
ceptive implant should be placed subdermally at the inner 
side of the upper non-dominant arm approximately 7 cm 
above the elbow crease in the groove between the biceps 
and the triceps [9]. If the implant cannot be visualized, the 
physician should perform two-dimensional radiography be-
fore blunt dissection with forceps to localize the distal end 
of the implant. In rare cases, the implants can be located at 
unexpected positions. A case of radiopaque subdermal im-
plant migration into the lung was reported in a 37-year-old 
woman [10]. In that case, radiography was helpful to localize 
the migrated rod owing to its radio-opacity.
In some cases, the implants were placed deeper than 
where they were supposed to be on ultrasonography. In 
cases 7 and 12, the implants were visualized 7.1 and 7.2 mm 
deep into the subcutaneous layer on ultrasonography, re-
spectively. However, they were located deeper than the mea-
Table 2. Measurements during the procedure and ultrasound findings
Case Time (min) Incision (mm) Depth in US (mm) Ultrasound findings Result
1 5 5 3.8 Anteromedial subcutaneous fat layer, intra fascia S
2 5 5 5.1 Medial aspect, 5 mm depth from skin S
3 5 5 9.3 Median nerve located right under proximal tip S
4 7 5 6.3 Superficial to the brachial artery S
5 3 5 6.8 Subcutaneous fat layer S
6 3 5 6.0 Right overriding brachial artery and vein S
7 10 5 7.1 Anteromedial subcutaneous fat layer S
8 15 5 7.9 Fascial layer, subcutaneous and muscle junction S
9 3 5 11.8 Subcutaneous fat layer S
10 3 5 9.0 Not adjacent neuromuscular bundle S
11 5 5 6.7 Subcutaneous fat layer S
12 7 5 7.2 Subcutaneous fat layer S
13 18 10 4.1 4 mm depth from the skin S
14 5 5 8.5 Subcutaneous fat layer S
15 7 10 10.9 Fascial layer, subcutaneous and muscle junction S
16 3 5 9.4 Anteromedial subcutaneous fat layer S
17 3 5 3.2 3 mm depth from the skin S
18 3 5 7.5 Medial aspect, 7.5 mm depth from skin S
19 25 10 12.7 Deeper than muscle fascia, probably intramuscle F
20 30 10 12.0 Intra-biceps muscle F
21 25 10 13.5 Deeper than muscle fascia, probably intramuscle F
Time, the time spent for trying to removal with or without success; US, ultrasound; S, success; F, failure.
Table 3. Mean depth, time and duration
Characteristic Fail (n=3) Success (n=18) P-value
Depth in US (mm) 12.73±0.75 7.26±2.74 0.003
Time (min) 26.67±2.89 6.12±4.62 <0.001
Duration (mon) 45.33±23.18 25.61±12.22 0.081
Data are presented as mean±standard deviation.
Depth in US, the depth from skin to the distal tip of implant mea-
sured in ultrasound; Time, the time spent for trying to removal with 
or without success; Duration, between insertion and removal of im-
plant.
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surement on ultrasonography, so the clinician had to explore 
the subdermal devices, which took more time than expected. 
Compression by the probe can artificially reduce the skin-to-
implant measurements. The radiologist should be cautious 
not to press the skin too hard. The underestimated depth of 
the implants consequently leads to the failure of removal.
If localization by ultrasonography is performed, the re-
moval rate of implants would be high as shown in this study. 
Therefore, if the rod is not palpable, removal should not be 
attempted blindly and the patient should be referred to facili-
ties where radiology consultation can be made.
This study suggests that high-frequency ultrasonography is 
a highly accurate method for localizing impalpable subder-
mal implants. Measurement of depth from the skin to the 
implant is worth discussing, describing ultrasonography find-
ings and recording the time spent for removal in each case. 
All the procedures were performed by a single experienced 
skillful clinician; therefore, no interobserver variation was 
observed. At the same time, however, the study is limited 
by the small number of participants, as this study was per-
formed by a single clinician in a single institution.
The aim of this paper was to show that removal of non-
palpable implants is possible without intravenous sedation in 
most cases. Intravenous sedation is also a burdensome pro-
cedure in an outpatient setting because it requires monitor-
ing of the patient’s condition and general anesthesia. Intrave-
nous sedation with local anesthesia is insufficient to remove 
deep implants because of the risk of bleeding or irritation of 
damaged nerves.
As shown earlier, the depth of the subdermal device is a 
significant factor that determines the success of implant re-
moval. We presented the cutoff value for removal with local 
anesthesia in an outpatient clinic setting. Within 12.0 mm 
of implant depth, all non-palpable implants were success-
fully removed in the outpatient setting with local anesthesia. 
However, if the depth of the implant is >12.0 mm, the re-
moval is not likely to succeed in the outpatient setting be-
cause patients may complain of pain or the clinician fails to 
explore the rods. To avoid unnecessary procedures, removal 
of the implant in the operating room with general anesthesia 
is recommended when the implant is >12.0 mm deep from 
the skin. This parameter helps in the removal of non-palpable 
implants with minimal complications and less invasiveness.
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